We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
New EU antitrust law burdens licensing.
- Authors
Louët, Sabine
- Abstract
The European Commission has implemented new Technology Transfer Block Exemption Regulations to define rules with which companies need to comply to be exempt from proving that a licensing agreement does not hinder competition. But the haphazard "one-size-fits-all" rules are a poor fit for biotech companies, which are dependent on licensing for income and to access technologies. Most biotech companies consider the guidelines complicated and disagree with some of the criteria necessary for exemption. For example, a licensing agreement will not be eligible for "block exemption" if the overall market share of both parties exceeds 20°4 if they are competitors or 30% if they are noncompetitors.
- Subjects
TECHNOLOGY transfer; LICENSE agreements; TECHNOLOGICAL innovations; BIOTECHNOLOGY industries; GUIDELINES; EUROPEAN Commission
- Publication
Nature Biotechnology, 2004, Vol 22, Issue 6, p643
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0604-643